E-400 CAP. FCO. C/30 PALMITATO DE Emicizumab 150 mg/mL

Description

Emicizumab 150 mg/mL

PRINCIPIO ACTIVO: ERITROMICINA BASE

/5 ML CAJA C/FCO

Tumores neuroendocrinos gastroenteropancreáticos

E-400 CAP. FCO. C/30 PALMITATO DE Emicizumab 150 mg/mLSUSTANCIA: E 400 CAP. FCO. C 30 FABRICANTE: GELCAPS

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy